BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation

NYSE:BXC • US09624H2085

62.12 USD
-1.82 (-2.85%)
At close: Mar 5, 2026
62.12 USD
0 (0%)
After Hours: 3/5/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BXC. BXC was compared to 47 industry peers in the Trading Companies & Distributors industry. While BXC seems to be doing ok healthwise, there are quite some concerns on its profitability. BXC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. BXC Profitability Analysis

1.1 Basic Checks

  • In the past year BXC was profitable.
  • In the past year BXC had a positive cash flow from operations.
  • Each year in the past 5 years BXC has been profitable.
  • Each year in the past 5 years BXC had a positive operating cash flow.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • BXC's Return On Assets of 0.01% is in line compared to the rest of the industry. BXC outperforms 40.43% of its industry peers.
  • BXC has a worse Return On Equity (0.04%) than 61.70% of its industry peers.
  • BXC's Return On Invested Capital of 1.69% is on the low side compared to the rest of the industry. BXC is outperformed by 65.96% of its industry peers.
  • BXC had an Average Return On Invested Capital over the past 3 years of 4.86%. This is below the industry average of 9.12%.
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROIC 1.69%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • BXC's Profit Margin of 0.01% is on the low side compared to the rest of the industry. BXC is outperformed by 61.70% of its industry peers.
  • BXC's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 1.02%, BXC is doing worse than 68.09% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BXC has declined.
  • With a Gross Margin value of 15.29%, BXC is not doing good in the industry: 82.98% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BXC has remained more or less at the same level.
Industry RankSector Rank
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BXC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BXC is destroying value.
  • BXC has less shares outstanding than it did 1 year ago.
  • BXC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BXC is higher compared to a year ago.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • BXC has an Altman-Z score of 3.37. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
  • BXC has a Altman-Z score of 3.37. This is comparable to the rest of the industry: BXC outperforms 59.57% of its industry peers.
  • The Debt to FCF ratio of BXC is 18.81, which is on the high side as it means it would take BXC, 18.81 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BXC (18.81) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
  • BXC has a Debt to Equity ratio (0.96) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Altman-Z 3.37
ROIC/WACC0.17
WACC9.89%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • BXC has a Current Ratio of 4.66. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • BXC has a better Current ratio (4.66) than 95.74% of its industry peers.
  • BXC has a Quick Ratio of 3.12. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
  • BXC's Quick ratio of 3.12 is amongst the best of the industry. BXC outperforms 95.74% of its industry peers.
Industry RankSector Rank
Current Ratio 4.66
Quick Ratio 3.12
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BXC Growth Analysis

3.1 Past

  • The earnings per share for BXC have decreased strongly by -85.11% in the last year.
  • BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -35.32% yearly.
  • BXC shows a small growth in Revenue. In the last year, the Revenue has grown by 0.05%.
  • BXC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.94% yearly.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%

3.2 Future

  • Based on estimates for the next years, BXC will show a very strong growth in Earnings Per Share. The EPS will grow by 85.45% on average per year.
  • The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. BXC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 65.39, which means the current valuation is very expensive for BXC.
  • BXC's Price/Earnings ratio is a bit more expensive when compared to the industry. BXC is more expensive than 63.83% of the companies in the same industry.
  • BXC is valuated expensively when we compare the Price/Earnings ratio to 26.74, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 111.32, BXC can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, BXC is valued a bit more expensive than 65.96% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.82, BXC is valued quite expensively.
Industry RankSector Rank
PE 65.39
Fwd PE 111.32
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BXC indicates a somewhat cheap valuation: BXC is cheaper than 70.21% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, BXC is valued cheaper than 85.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.88
EV/EBITDA 10.51
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BXC's earnings are expected to grow with 85.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.45%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BXC Dividend Analysis

5.1 Amount

  • BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BXC Fundamentals: All Metrics, Ratios and Statistics

BLUELINX HOLDINGS INC

NYSE:BXC (3/5/2026, 8:04:00 PM)

After market: 62.12 0 (0%)

62.12

-1.82 (-2.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24
Earnings (Next)04-27
Inst Owners99.25%
Inst Owner Change1.62%
Ins Owners2.22%
Ins Owner Change0.01%
Market Cap488.88M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target78.03 (25.61%)
Short Float %6.11%
Short Ratio4.82
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.05%
EPS NY rev (1m)0%
EPS NY rev (3m)-28.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 65.39
Fwd PE 111.32
P/S 0.17
P/FCF 14.88
P/OCF 8.18
P/B 0.79
P/tB 1.06
EV/EBITDA 10.51
EPS(TTM)0.95
EY1.53%
EPS(NY)0.56
Fwd EY0.9%
FCF(TTM)4.17
FCFY6.72%
OCF(TTM)7.6
OCFY12.23%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.04%
ROCE 2.25%
ROIC 1.69%
ROICexc 2.37%
ROICexgc 2.83%
OM 1.02%
PM (TTM) 0.01%
GM 15.29%
FCFM 1.11%
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 18.81
Debt/EBITDA 8.51
Cap/Depr 67.49%
Cap/Sales 0.91%
Interest Coverage 0.64
Cash Conversion 85.42%
Profit Quality 15000.5%
Current Ratio 4.66
Quick Ratio 3.12
Altman-Z 3.37
F-Score5
WACC9.89%
ROIC/WACC0.17
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year80.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%

BLUELINX HOLDINGS INC / BXC FAQ

What is the fundamental rating for BXC stock?

ChartMill assigns a fundamental rating of 4 / 10 to BXC.


What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?

ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.


What is the profitability of BXC stock?

BLUELINX HOLDINGS INC (BXC) has a profitability rating of 3 / 10.


How financially healthy is BLUELINX HOLDINGS INC?

The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.